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M. Arif Ashraf4*

Abstract
Objective: MPDB 2.0 is built to be the continuation of MPDB 1.0, to serve as a more comprehensive data repertoire
for Bangladeshi medicinal plants, and to provide a user-friendly interface for researchers, health practitioners, drug
developers, and students who wish to study the various medicinal & nutritive plants scattered around Bangladesh and
the underlying phytochemicals contributing to their efficacy in Bangladeshi folk medicine.
Results: MPDB 2.0 database (https://www.medicinalplantbd.com/) comprises a collection of more than five hundred
Bangladeshi medicinal plants, alongside a record of their corresponding scientific, family, and local names together
with their utilized parts, information regarding ailments, active compounds, and PubMed ID of related publications.
While medicinal plants are not limited to the borders of any country, Bangladesh and its Southeast Asian neighbors
do boast a huge collection of potent medicinal plants with considerable folk-medicinal history compared to most
other countries in the world. Development of MPDB 2.0 has been highly focused upon human diseases, albeit many
of the plants indexed here can serve in developing biofuel (e.g.: Jatropha curcas used in biofuel) or bioremediation
technologies (e.g.: Amaranthus cruentus helps to reduce cadmium level in soil) or nutritive diets (Terminalia chebula
can be used in nutritive diets) or cosmetics (Aloe vera used in cosmetics), etc.
Keywords: MPDB2.0, Medicinal plant, Medicinal plant database of Bangladesh, Folk medicine
Introduction
Since ancient times nature has always provided its
favoured children (humans) with both remedies for fighting diseases and nutrition products to maintain good
health via plants full of potent medicinal properties and
nutritive values, [1] and our forefathers have utilized this
boon from mother nature to the fullest, a sign of which
can be still found in the local folk medicinal therapies [2–
4]. While our predecessors hardly understood the underlying mechanisms and chemical mediators responsible
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for the efficacy of these plants, recent advancement in
technology (which includes techniques, instrumentation,
and automation in isolation and structural characterization) allows us to learn the underlying mechanisms of
these herbal treatments in depth [5, 6] and discover the
full potential for the usage of these plants full of potent
medicinal properties and nutritive values [7, 8].
Several studies in recent times have suggested that
plant active compounds or secondary metabolites possess immense potential for application in both research
and clinical industries, for instance in developing
nutraceuticals, nutrition products, biofuel technology, insecticides, flavouring agents, colouring agents,
smelling agents, or fragrance, etc. [9–13]. According to
records approximately 4,20,000 plant species are existing in nature among which about 10,000 to 15,000 plants
have been studied for their medicinal and nutritional
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properties and about 200 of these plants or their active
compounds have been adopted in western medicines [14,
15]. While natural substances are no longer used in modern medicinal therapies since the early decades of the last
century, studies on bioactive molecules originating from
plants continue to play a vital role in the development
of novel medicinal therapies for emerging new diseases
[16–18] as the parallel advancement of both biology and
technology opens up an inexhaustible repertoire of naturally occurring compounds that have the potential to lead
to the development of efficient and novel treatment strategies for diseases, both old and new [1, 7, 15].
MPDB 2.0 database (plants of 122 family, 381 genus
and 557 species), like MPDB 1.0 [19] is a user-friendly
interface committed to rendering information (including their scientific names, family names, local names,
utilized parts, related ailments, and active compounds)
of plants around Bangladesh which have been suggested to have potent medicinal and/or nutritive properties, for both national and international researchers,
health practitioners, drug developers and students who
wish to study the medicinal and nutritional plants of

Table 1 Major plant families in the MPDB2.0
Family

No of entries

% of each families

Amaranthaceae

10

1.795332

Apocynaceae

13

2.333932

Araceae

14

2.513465

Asteraceae

25

4.48833

Convolvulaceae

11

1.974865

Cyperaceae

11

1.974865

Euphorbiaceae

28

5.02693

Fabaceae

50

8.976661

Lamiaceae

31

5.56553

Lauraceae

11

1.974865

Malvaceae

13

2.333932

Poaceae

21

3.770197

Rubiaceae

11

1.974865

Rutaceae

11

1.974865

Solanaceae

19

3.411131

Other

278

49.91023

Total

557

100
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Fig. 1 Pie chart demonstrates the most prominent plant families, expressed as percentage, from the MPDB 2.0. Families contain 10 or more than 10
plants are represented here individually, and all other families were listed as “other” category. Details numbers are provided in the Table 1
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Fig. 2 Involvement of medicinal plant databased such as MPDB1.0 and MPDB2.0 in drug discovery initiative

Bangladesh. Interestingly, we have found that certain
families are more prominent and appeared in a higher
frequency in the collection of medicinal plant, MPDB
2.0. For instance, Asteraceae, Euphorbiaceae, Fabaceae,
Lamiaceae, Poaceae, Solanaceae families are major
source of medicinal plants in our database (Fig. 1;
Table 1). To help the scientific community in advancing biological sciences the authors have dedicated the
MPDB 2.0 database to be an open-source server. An
updated medicinal plant database will enhance the
scientific community to advance in the field of drug
discovery (Fig. 2). In addition, we have created a promotional animated video (https://w ww.youtube.com/
watch?v=tibx8M A6-Xs) for the MPDB 2.0 to reach
wider audience and researchers.

Main text
Methods and materials
Literature mining

To collect the necessary plant data for the MPDB 2.0
database, a cluster of 43 literatures retaining information regarding medicinal and nutritive values along with
respective folk therapies of Bangladeshi medicinal plants
corresponded by both national and international research
groups have been studied. The scientific names, family
names, local names, utilized parts, and active compounds

or secondary metabolites of the related plants have been
included in the search parameters. To identify synonymous plant scientific names and reduce redundancies,
The Plant List web server (http://www.theplantlist.org/)
has been utilized.
Active compounds

For assembling literature retaining information of active
compounds of the indexed Bangladeshi medicinal plants
a separate search was conducted by two researchers independently and the PubMed web server (https://pubmed.
ncbi.nlm.nih.gov/) has been exclusively utilized for this.
The scientific names and scientific name synonyms have
been implemented as search keywords.
Database preparation

VueJS, (https://vuejs.org/) a Javascript framework has
been implemented for building the frontend of MPDB
2.0. ElasticSearch, (https://www.elastic.co/) a distributed storage and analytics engine has been utilized as
the backend of this database. For ensuring the robustness
of search functionality Edge-ngram tokenizer has been
employed alongside ElasticSearch’s standard tokenizer
when indexing the documents. FastAPI, (https://fastapi.
tiangolo.com/) a Python web framework has been utilized in building the middleware for this database which
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Fig. 3 A Interface of MPDB2.0 database. B Keyword search result demonstrates related plant, their scientific names, source of plant, utilized parts,
ailment, available active compounds, source of article, and hyperlinked PubMed ID of the reference papers
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translates the request-response between frontend and
ElasticSearch.
Database access

The MPDB 2.0 database contains five pages among which
the “Search” (Fig. 3) page displays and gives access to the
indexed Bangladeshi medicinal plants information along
with their active compounds list. The search functionality within this page enables a user to query the database
using one or more keywords (scientific name, local name,
utilized parts, ailments, active compounds, and PMID)
for normal or Boolean search. Every keyword entered is
attempted to match with all the fields unless the field is
specified. Several singles keyword queries matched with
different fields are illustrated in Fig. 3. Users can search
by stitching the keywords with AND/OR operator. Some
plant entries contain multiple PMID entries as when collecting active compounds data, the authors used multiple
references, in such cases clicking on the PMID section
allows the users to see which active compounds belong
to which publications, improving the overall user-friendliness of the database (Fig. 3).
Conclusion

MPDB 2.0 is the continuation of MPDB 1.0, while it is
established upon the same initial structure as MPDB
1.0, it contains a much larger data repository compared
to its predecessor and the released version is much more
refined and user friendly than MPDB 1.0. The MPDB 2.0
database has been dedicated to being a promising webserver engine for the initial screening of phytochemicals
in silico drug development.

Limitations
In order to reduce over-complexity, when some plants
had multiple publications describing different active
compounds composition, only the publication with the
highest number of validated active compounds have
been indexed in the database, which reduces the possible data density of the database. Also, the plant information indexed in MPDB 2.0 with the exceptions of active
compounds and PubMed IDs have been collected from
publications on Bangladeshi medicinal plants, since
there has been a server lack of wet lab works on these
Bangladeshi plants in Bangladesh, and their metabolite
composition has not been evaluated locally. A separate
literature mining was conducted to identify the active
compounds of these plant species from publications and
research works of other countries. Since the geodemographic distribution of plants has a considerable effect on
the composition of their metabolites, the accuracy of the
active compounds listed in the database remains open to
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questions. The authors hope to remove these inadequacies in future editions of the MPDB.
Abbreviations
MPDB 2.0: Medicinal plant database 2.0; PMID: PubMed unique identifier.
Acknowledgements
The authors would like to thank researchers around the globe for their relentless effort to put together the information on medicinal plants.
Authors’ contributions
NH and RC prepared the background material for the database. RAA, MAM,
and MKH supervised and coordinated the project. MAA adopted the idea and
coordinated the database project. All the authors involved in this project participate in writing and editing the final version of the manuscript. All authors
read and approved the final manuscript
Funding
This project is currently not funded.
Availability of data and materials
Data used in this study or produced is either available from the public domain
or mentioned here in the manuscript. Apart from that, authors always welcome to share the data required for reviewers and other researchers.

Declarations
Ethics approval and consent to participate
Not applicable.
Consent for publication
Not applicable.
Competing interests
Authors declare no competing interests.
Author details
1
Department of Biochemistry and Molecular Biology, Tejgaon College,
National University of Bangladesh, Gazipur 1704, Bangladesh. 2 Bio-Bio-1
Bioinformatics Research Foundation, Dhaka, Bangladesh. 3 Shahjalal University
of Science and Technology, Sylhet, Bangladesh. 4 Biology department, University of Massachusetts Amherst, Amherst, MA, USA.
Received: 5 April 2021 Accepted: 29 July 2021

References
1. Ashraf MA. Phytochemicals as potential anticancer drugs: time to ponder
nature’s bounty. Biomed Res Int. 2020;2020:1–7.
2. Ong HG, Kim YD. Medicinal plants for gastrointestinal diseases among
the Kuki–Chin ethnolinguistic groups across Bangladesh, India, and
Myanmar: a comparative and network analysis study. J Ethnopharmacol.
2020;251:112415.
3. Asadi-Samani M, Kafash-Farkhad N, Azimi N, Fasihi A, Alinia-Ahandani
E, Rafieian-Kopaei M. Medicinal plants with hepatoprotective activity in
Iranian folk medicine. Asian Pac J Trop Biomed. 2015;5:146–57.
4. Martins N, Ferreira ICFR, Barros L, Carvalho AM, Henriques M, Silva S.
Plants used in folk medicine: the potential of their hydromethanolic
extracts against Candida species. Ind Crops Prod. 2015;66:62–7.
5. Ma X, Meng Y, Wang P, Tang Z, Wang H, Xie T. Bioinformatics-assisted,
integrated omics studies on medicinal plants. Brief Bioinform.
2020;21:1857–74.
6. De Silva AM, Manville RW, Abbott GW. Deconstruction of an African folk
medicine uncovers a novel molecular strategy for therapeutic potassium
channel activation. Sci Adv. 2018;4:eaav024.

Hussain et al. BMC Res Notes

7.
8.
9.
10.

11.
12.
13.
14.

(2021) 14:301

Wangkheirakpam S. Traditional and folk medicine as a target for drug discovery. In: Natural products and drug discovery: an integrated approach;
2018. pp. 29–56.
Hassannia B, Logie E, Vandenabeele P, Berghe TV, Berghe WV. Withaferin
A: from ayurvedic folk medicine to preclinical anti-cancer drug. Biochem
Pharmacol. 2020;173:113602.
McChesney JD, Venkataraman SK, Henri JT. Plant natural products: back
to the future or into extinction? Phytochemistry. 2007;68:2015–22.
Goossens A, Häkkinen ST, Laakso I, Seppänen-Laakso T, Biondi S, De
Sutter V, et al. A functional genomics approach toward the understanding of secondary metabolism in plant cells. Proc Natl Acad Sci U S A.
2003;100:8595–600.
Birari RB, Bhutani KK. Pancreatic lipase inhibitors from natural sources:
unexplored potential. Drug Discov Today. 2007;12:879–89.
Chartrain M, Salmon PM, Robinson DK, Buckland BC. Metabolic engineering and directed evolution for the production of pharmaceuticals. Curr
Opin Biotechnol. 2000;11:209–14.
Wang Y, Fan C, Hu H, Li Y, Sun D, Wang Y, et al. Genetic modification of
plant cell walls to enhance biomass yield and biofuel production in
bioenergy crops. Biotechnol Adv. 2016;34:997–1017.
Jamshidi-Kia F, Lorigooini Z, Amini-Khoei H. Medicinal plants: past history
and future perspective. J HerbMed Pharmacol. 2018;7:1–7.

Page 6 of 6

15. Li JWH, Vederas JC. Drug discovery and natural products: end of an era or
an endless frontier? Science. 2009;325:161–5.
16. Ak M. A brief review of traditional plants as sources of pharmacological
interests. Open J Plant Sci. 2019;4(1):001–8.
17. Rahal-Bouziane H. The powerful healing effect of traditional medicine
for the treatment of certain chronic diseases: one of the means to better
defeat Covid-19. J Basic Appl Res Biomed. 2020;6:106–13.
18. Rakib A, Paul A, Nazim Uddin Chy M, Sami SA, Baral SK, Majumder M, et al.
Biochemical and computational approach of selected phytocompounds
from Tinospora crispa in the management of COVID-19. Molecules.
2020;25(17):3936.
19. Ashraf MA, Khatun A, Sharmin T, Mobin F, Tanu AR, Morshed T, et al.
MPDB 1.0: a medicinal plant database of Bangladesh. Bioinformation.
2014;10:384–6.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Ready to submit your research ? Choose BMC and benefit from:

• fast, convenient online submission
• thorough peer review by experienced researchers in your field
• rapid publication on acceptance
• support for research data, including large and complex data types
• gold Open Access which fosters wider collaboration and increased citations
• maximum visibility for your research: over 100M website views per year
At BMC, research is always in progress.
Learn more biomedcentral.com/submissions

